November 30, 2021: For molnupiravir, the balance of benefits and risks may differ between different types of patients, and not all types of patients were studied.
Read More »Tag: covid19
Avoiding the Subject: On Pfizer Vaccine Quality Control, FDA Says Less than European Counterpart
Project on Government Oversight, March 19, 2021: The Project on Government Oversight’s new report about the Pfizer COVID Vaccine raises questions about why the FDA did not publicly disclose quality control concerns that were publicly raised in Europe. We ask: Is “adequate” quality control good enough?
Read More »Opinion: Maryland’s reopening, especially of sports stadiums, is too soon
The Washington Post Letters to the Editor, March 15, 2021: Gov. Larry Hogan (R) is reopening sports stadiums to 50 percent capacity and consulting Dr. Robert Redfield for his COVID-19 response. Both decisions create an enormous opportunity for the coronavirus to spread.
Read More »What you need to know about J&J’s newly authorized one-shot COVID-19 vaccine
ScienceNews: February 27, 2021. On February 27, the FDA authorized Johnson & Johnson’s COVID-19 vaccine for use in the U.S. The other two authorized vaccines are made by Pfizer and Moderna. None are FDA approved. All show effectiveness, but there are too few serious COVID-19 cases in any of the studies to conclude how well it prevents hospitalizations or deaths.
Read More »Dr. Diana Zuckerman’s Testimony on Moderna’s COVID Vaccine Before the FDA Advisory Committee
December 17, 2020: We need at least 1 year of blinded, randomized, controlled data. We agree that FDA should delay access to vaccines by members of the placebo group unless they are in priority populations.
Read More »